Effect of half-dose and standard-dose conjugated equine estrogens combined with natural progesterone or dydrogesterone
on components of metabolic syndrome in healthy postmenopausal women: A Randomized controlled trial.
and other progestins in benign breast disease: an overview.
The aim of the study was to observe and analyze the efficacy and safety of dydrogesterone
in threatened abortion.
in secondary amenorrhea: results of a double-blind, placebo-controlled, randomized study.
According to one study from El-Zibdeh, miscarriage rates were significantly lower in the group treated with dydrogesterone
as compared to the untreated group (16).
(1) and its microbial hydroxylated metabolite 9AY,12AY-dihydroxy- 9AY,10a-pregna-4,6-diene-3,20-dione (2) were screened for their anti-glycation and a-glucosidase inhibitory activities.
Objective: To study the efficacy of dydrogesterone
in pregnant women with threatened miscarriage in the first trimester.
Use of dydrogesterone
in hormone replacement therapy.
Walch K, Hefler L, Nagele F Oral dydrogesterone
treatment during the first trimester of pregnancy: the prevention of miscarriage study (PROMIS).
Progesterone of dydrogesterone
(a nonbioidentical hormone not available in the U.
Fournier and associates, for example, found that EPT regimens containing progesterone or dydrogesterone
were associated with a lower risk of breast cancer than other types of progestogen.
Estrogen-induced lipid changes were opposed according to type of progestogen, with dydrogesterone
and medrogestone having the least effect, followed by progesterone, cyproterone acetate, medroxyprogesterone acetate, transdermal norethindrone acetate, norgestrel, and oral norethindrone acetate.